Cerebellar assessment for patients receiving high-dose cytarabine: a standardized approach to nursing assessment and documentation.
Cerebellar toxicity is a known potential adverse effect of high-dose cytarabine chemotherapy. Oncology nurses are expected to assess patients receiving high-dose cytarabine for cerebellar toxicity prior to administering each dose. Information regarding cerebellar assessment techniques and documentation of findings is limited in the nursing literature. This article provides nurses with a standardized approach for cerebellar function assessment and documentation of assessment finding for patients receiving high-dose cytarabine therapy.
Brown
Corinne
C
Sarasota Memorial Hospital, Sarasota, FL, USA. at cbrown@hotmail.com
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002531:Cerebellum / Q000187:drug effects*; D003561:Cytarabine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009730:Nursing Assessment; D009737:Nursing Records
D000970:Antineoplastic Agents; D003561:Cytarabine